Author's posts
Banner hospitals tap acute care executive
John Groesbeck was named senior vice president of acute care operations for Banner Health’s Arizona community hospitals.
Hospitals grapple with hurricane aftermath: 8 things to know
Some hospitals are beginning to recover from the storm damage, flooding and power outages caused by Hurricane Helene.
Houston Methodist taps former Advocate Health CFO
Houston Methodist has tapped Anthony DeFurio as executive vice president and CFO. Mr. DeFurio succeeds Kevin Burns, who retired at the end of September, according to an Oct. 2 news release shared with Becker’s.
Former Texas hospital CEO to pay 5.3M to resolve false claims case
The former CEO of a Texas hospital has agreed to pay more than $5.3 million to resolve allegations under the False Claims Act involving laboratory testing.
OpenAI value doubles to $157B this year
OpenAI raised $6.6 billion funding and is now valued at $157 billion, according to The Wall Street Journal.
Should health systems monetize patient data?
Health systems have a large amount of patient data through EHRs and other digital platforms managing administrative tasks and clinical care.
California sues 2nd hospital in a week
California attorney general Rob Bonta filed a lawsuit against AHMC Healthcare on Oct. 2, claiming the Alhambra-based health system’s service reductions at one Bay Area hospital and closure of another facility violate conditions set by the state when it…
What 'literal heavy lifting' taught Mount Sinai's CEO
The sources from which leaders in academic medicine draw motivation might not be considered typical, Mount Sinai Health System CEO Brendan Carr, MD, told Becker’s.
Louisiana hospital CEO to retire after 8 years
Larry Meese, CEO of Zachary, La.-based Lane Regional Medical Center, will retire Oct. 31.
Eli Lilly invests $4.5B to boost manufacturing efficiency: 4 notes
Eli Lilly is building a $4.5 billion facility in Indiana that will combine research and production, aiming to enhance manufacturing efficiency and accelerate the development of clinical trial medicines, the drugmaker said Oct. 2.
